BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25420630)

  • 1. Synergistic effects of eukaryotic co-expression plasmid-based STAT3-specific siRNA and LKB1 on ovarian cancer in vitro and in vivo.
    Pan Y; Zhang L; Zhang X; Liu R
    Oncol Rep; 2015 Feb; 33(2):774-82. PubMed ID: 25420630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of plasmid-based Stat3-specific short hairpin RNA and GRIM-19 on PC-3M tumor cell growth.
    Zhang L; Gao L; Li Y; Lin G; Shao Y; Ji K; Yu H; Hu J; Kalvakolanu DV; Kopecko DJ; Zhao X; Xu DQ
    Clin Cancer Res; 2008 Jan; 14(2):559-68. PubMed ID: 18223232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effects of eukaryotic coexpression plasmid carrying LKB1 and FUS1 genes on lung cancer in vitro and in vivo.
    Li L; Yu C; Ren J; Ye S; Ou W; Wang Y; Yang W; Zhong G; Chen X; Shi H; Su X; Chen L; Zhu W
    J Cancer Res Clin Oncol; 2014 Jun; 140(6):895-907. PubMed ID: 24659339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmid-based Stat3-specific siRNA and GRIM-19 inhibit the growth of thyroid cancer cells in vitro and in vivo.
    Wang GM; Ren ZX; Wang PS; Su C; Zhang WX; Liu ZG; Zhang L; Zhao XJ; Chen G
    Oncol Rep; 2014 Aug; 32(2):573-80. PubMed ID: 24899100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of STAT3 by shRNA inhibits the growth of CAOV3 ovarian cancer cell line in vitro and in vivo.
    Huang F; Tong X; Fu L; Zhang R
    Acta Biochim Biophys Sin (Shanghai); 2008 Jun; 40(6):519-25. PubMed ID: 18535750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-17 promotes normal ovarian cancer cells to cancer stem cells development via suppression of the LKB1-p53-p21/WAF1 pathway.
    Liu T; Qin W; Hou L; Huang Y
    Tumour Biol; 2015 Mar; 36(3):1881-93. PubMed ID: 25510663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient inhibition of intraperitoneal ovarian cancer growth in nude mice by liposomal delivery of short hairpin RNA against STAT3.
    Jiang Q; Dai L; Cheng L; Chen X; Li Y; Zhang S; Su X; Zhao X; Wei Y; Deng H
    J Obstet Gynaecol Res; 2013 Mar; 39(3):701-9. PubMed ID: 23003327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmid-based Survivin shRNA and GRIM-19 carried by attenuated Salmonella suppresses tumor cell growth.
    Liu YB; Zhang L; Guo YX; Gao LF; Liu XC; Zhao LJ; Guo BF; Zhao LJ; Zhao XJ; Xu DQ
    Asian J Androl; 2012 Jul; 14(4):536-45. PubMed ID: 22580637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effects of signal transducer and activator of transcription 3 siRNA on human breast cancer in xenograft mice.
    Yang Z; Cai JH; Xie SJ; Li GX; Song WQ; Yan QH; Yan L; Zhang F
    Chin Med J (Engl); 2011 Jun; 124(12):1854-61. PubMed ID: 21740845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor suppressor LKB1 inhibits activation of signal transducer and activator of transcription 3 (STAT3) by thyroid oncogenic tyrosine kinase rearranged in transformation (RET)/papillary thyroid carcinoma (PTC).
    Kim DW; Chung HK; Park KC; Hwang JH; Jo YS; Chung J; Kalvakolanu DV; Resta N; Shong M
    Mol Endocrinol; 2007 Dec; 21(12):3039-49. PubMed ID: 17761947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of tumor suppressor LKB1 by honokiol abrogates cancer stem-like phenotype in breast cancer via inhibition of oncogenic Stat3.
    Sengupta S; Nagalingam A; Muniraj N; Bonner MY; Mistriotis P; Afthinos A; Kuppusamy P; Lanoue D; Cho S; Korangath P; Shriver M; Begum A; Merino VF; Huang CY; Arbiser JL; Matsui W; Győrffy B; Konstantopoulos K; Sukumar S; Marignani PA; Saxena NK; Sharma D
    Oncogene; 2017 Oct; 36(41):5709-5721. PubMed ID: 28581518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth inhibition induced by short hairpin RNA to silence survivin gene in human pancreatic cancer cells.
    Shen YM; Yang XC; Song ML; Qin CH; Yang C; Sun YH
    Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):69-77. PubMed ID: 20133233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibitory effect of silencing STAT3 gene with short hairpin RNA mediated by polyamidoamine dendrimers on growth of prostate cancer].
    Zhao WM; Xiu YC; Xu Y; Wang YM; Cheng ZK; Yu Q; Kong DL
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):575-9. PubMed ID: 18210874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of LKB1 suppresses Stat3 activity to promote the proliferation of esophageal carcinoma cells.
    Wang YQ; Dai WM; Chu XY; Yang B; Zhao M; Sun Y
    Mol Med Rep; 2014 Jun; 9(6):2400-4. PubMed ID: 24676538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual PLK1 and STAT3 inhibition promotes glioblastoma cells apoptosis through MYC.
    Wang H; Tao Z; Feng M; Li X; Deng Z; Zhao G; Yin H; Pan T; Chen G; Feng Z; Li Y; Zhou Y
    Biochem Biophys Res Commun; 2020 Dec; 533(3):368-375. PubMed ID: 32962858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo.
    Gao L; Zhang L; Hu J; Li F; Shao Y; Zhao D; Kalvakolanu DV; Kopecko DJ; Zhao X; Xu DQ
    Clin Cancer Res; 2005 Sep; 11(17):6333-41. PubMed ID: 16144938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of semaphorin4D gene silencing on malignant behavior of human ovarian cancer SKOV3 cells].
    Chen Y; Zhang L; Wu HJ; Liu WX; Hao Q
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):324-30. PubMed ID: 21875458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
    Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
    Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition.
    Selvendiran K; Ahmed S; Dayton A; Kuppusamy ML; Rivera BK; Kálai T; Hideg K; Kuppusamy P
    Cancer Biol Ther; 2011 Nov; 12(9):837-45. PubMed ID: 21885917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A potent oncolytic adenovirus selectively blocks the STAT3 signaling pathway and potentiates cisplatin antitumor activity in ovarian cancer.
    Han Z; Hong Z; Gao Q; Chen C; Hao Z; Ji T; Hu W; Yan Y; Feng J; Liao S; Wu P; Wang D; Wang S; Zhou J; Ma D
    Hum Gene Ther; 2012 Jan; 23(1):32-45. PubMed ID: 21875334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.